Poly Medicure Limited (BOM: 531768)

India flag India · Delayed Price · Currency is INR
2,655.15
-68.20 (-2.50%)
At close: Dec 19, 2024
76.58%
Market Cap 263.22B
Revenue (ttm) 15.22B
Net Income (ttm) 2.95B
Shares Out 101.33M
EPS (ttm) 30.63
PE Ratio 84.81
Forward PE 67.42
Dividend 3.00 (0.12%)
Ex-Dividend Date Sep 19, 2024
Volume 11,692
Open 2,650.75
Previous Close 2,723.35
Day's Range 2,622.00 - 2,679.80
52-Week Range 1,360.95 - 3,350.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 22, 2024

About Poly Medicure

Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1995
Employees 6,300
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531768
Full Company Profile

Financial Performance

In 2023, Poly Medicure's revenue was 13.76 billion, an increase of 23.36% compared to the previous year's 11.15 billion. Earnings were 2.58 billion, an increase of 44.05%.

Financial Statements

News

Top market losers today: ZF Commercial India plunges 12.85%, GE Vernova down 5.00%, Prestige Estates drops 3.59% in morning trade

In morning trade, at 9:58AM, the market witnessed significant losses across various sectors, with the following stocks leading the decliners: ZF Commercial India Ltd. tumbled 12.85% to ₹12,544.40, she...

24 days ago - Business Upturn

Poly Medicure Q2 Results: Revenue surges 9.15% YoY to ₹420.01 crore, Net Profit surges 40.64% YoY

Poly Medicure has reported robust financial results for Q2 FY24, showcasing significant growth both year-on-year (YoY) and quarter-on-quarter (QoQ). The company’s consolidated revenue and net profit f...

7 weeks ago - Business Upturn

Stock market update: Q2 FY25 results today for Sumitomo Chemical, Pfizer, Poly Medicure, Firstsource, Anant Raj, CAMS, Kalpatru, Railtel and more

A variety of companies across the chemical, pharmaceutical, healthcare, technology, and infrastructure sectors are set to release their Q2 FY25 earnings results today. Investors and analysts will focu...

7 weeks ago - Business Upturn

Top gainers in today’s market: Aptus surges 9.20%, BSE up 7.80%, Poly Medicure jumps 6.24%, CDSL rises 5.26%

As of 12:33 PM, the stock market witnessed notable movements with several companies leading the charge. Among the top gainers, Aptus Value Housing Finance, BSE Limited, and Poly Medicure emerged as st...

2 months ago - Business Upturn

Poly Medicure shares rise nearly 2% after raising ₹1,000 crore through QIP

Poly Medicure Ltd. saw its shares rise nearly 2% after the company successfully raised ₹1,000 crore through a Qualified Institutional Placement (QIP). The institutional share sale was completed on Thu...

4 months ago - Business Upturn

Stock to watch today: Poly Medicure launches QIP to raise ₹1,000 crore

Poly Medicure has initiated a Qualified Institutional Placement (QIP) aiming to raise ₹1,000 crore, according to CNBC-TV18. This move is set to result in a 5.54% equity dilution based on the company’s...

4 months ago - Business Upturn